UnitedHealth Group shares rose after TD Cowen upgraded the stock, as investors bet the worst of the recent selloff may be priced in even as the insurer still faces margin pressure from elevated medical costs.
UnitedHealth rises after TD Cowen upgrade

The move matters because UnitedHealth remains the bellwether for managed care, and any shift in sentiment around the stock can ripple through the broader health insurance group. After plunging to 2026 lows below $280 late last month, the shares closed at $339.85 on Friday, up from $330.48 a day earlier, but still well below the $424.98 high reached in October.
The rebound comes after a brutal stretch for the stock that drove its relative-strength reading to deeply oversold levels before the recent recovery. The 14-day RSI was 27.9 in the latest data, while the shares remained below the 50-day moving average of $388.70, underscoring how far the stock has fallen even after the upgrade.
UnitedHealth has been under pressure as medical costs stay above historical levels, according to its latest 10-Q, even as fewer people served and favorable reserve development helped offset some of that strain. That combination has left investors focused on whether earnings growth can stabilize without a bigger hit to margins.
The upgrade also lands in a market that has been punishing health insurers broadly. Peer stocks have been volatile too, with Cigna and CVS both weaker in recent sessions, reflecting ongoing concern about utilization, pricing and profitability across the sector.
For investors, the key question is whether the upgrade marks the start of a durable rerating or just a short-covering bounce after a steep selloff. Near term, the shares will likely trade on any further commentary around medical cost trends, pricing discipline and how quickly management can restore confidence in earnings momentum.
| Entity | Gains | Losses |
|---|---|---|
| UnitedHealth | ▲Sentiment reset, bargain buyers | ▼Skeptics on margin recovery |
| TD Cowen | ▲Visibility on a timely call | ▼Risk if costs stay elevated |
| Managed care bulls | ▲Potential rebound trade | ▼Need proof of earnings stability |
| Cigna and CVS | ▲Sector comparison support if fear eases | ▼More scrutiny on utilization and costs |



